Revolutionizing care for rare genitourinary tumours

Management of rare genitourinary malignancies often depends on individual physicians' discretion, resulting in non-standardized care. Furthermore, patients experience worse clinical outcomes than patients with common malignancies. Collaborative efforts such as the Global Society of Rare Genitourinary Tumors (GSRGT) are therefore necessary.